Jason Bloom
Otolaryngology/Facial Plastic Surgery · Bryn Mawr, PANPI 1184780108
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Galderma Laboratories, L.p. accounts for 63.9% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $186,520 and has fallen 52.0% since, to $89,603 in 2025. Among otolaryngology/facial plastic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 703 payments — averaging $1020.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$459K
- AbbVie$196K
- Merz North America, Inc.$40K
- Revance Therapeutics, Inc.$11K
- Endo Pharmaceuticals Inc.$9K
- Galderma Research & Development, LLC$3K
- plus $731 from 12 others
Across 5 payments — averaging $3750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merz North America, Inc.$19K
What the payments were for
- Consulting fees$226,96632%
- Speaking & faculty fees$424,43959%
- Travel & lodging$52,0107%
- Food & beverage$14,0542%
- Education$620%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 369 | $458,533 |
| AbbVie(2 entities) | 250 | $196,092 |
| Merz North America, Inc. | 39 | $39,561 |
| Revance Therapeutics, Inc. | 17 | $10,731 |
| Endo Pharmaceuticals Inc. | 10 | $8,907 |
| Galderma Research & Development, LLC | 1 | $2,975 |
| Medtronic | 1 | $150 |
| Motiva USA, LLC | 1 | $115 |
| Baxter Healthcare | 3 | $68 |
| Spirair, Inc. | 1 | $68 |
| Reflow Medical Inc | 2 | $64 |
| Abbott | 1 | $56 |
| Chiesi USA, Inc. | 1 | $54 |
| Stryker | 1 | $35 |
| Acist Medical Systems, Inc. | 1 | $34 |
| Asahi Intecc USA, Inc. | 1 | $29 |
| Solta Medical, A Division Of Bausch Health US, LLC | 2 | $29 |
| Medela LLC | 2 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$46,012
- BOTOX$36,896
- XEOMIN$11,213
- DAXXIFY$10,200
- KYBELLA$1,950
- DYSPORT$196
- ASCLERA$128
- Motiva Implant Matrix$115
How this compares
$717,531 in reported general payments places this provider in the 95th percentile of 21 otolaryngology/facial plastic surgery providers in Pennsylvania.
See all otolaryngology/facial plastic surgery providers in Pennsylvania →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $78 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Bryn Mawr
- Donald SessoNorristown$23K
- Sean CarrollErie$6K
- Melissa SchwartzElkins Park$5K
- Adam MariottiExton$5K
- Jeffrey BrigliaLanghorne$4K
- Aykut UnsalPhiladelphia$4K
- Michael PicarielloExton$4K
- Raphael GabayPhiladelphia$4K
- Jose UribeBethlehem$4K
- Harleen SethiPhiladelphia$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.